Início › Leucemia Mieloide Aguda › Washington

Ensaios clínicos de Leucemia Mieloide Aguda em Washington

41 estudos para Leucemia Mieloide Aguda estão buscando participantes em locais em Washington.

Cidades em Washington

Texto oficial do estudo (Inglês)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
e mais 19

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1

Idades de 12 a 78 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT03802695

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Swedish Medical Center-First Hill, Seattle

RecrutandoFase 2

Idades de 18 a 59 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Swedish Cancer Institute, Seattle
Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Fred Hutchinson Cancer Center, Seattle
e mais 2

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Fred Hutchinson Cancer Center, Seattle
e mais 2

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06317649

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Swedish Medical Center-First Hill, Seattle

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Swedish Medical Center-First Hill, Seattle

RecrutandoFase 2

Idades de 18 a 59 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT05554406

FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07645469

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT04375631

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

Fred Hutch/University of Washington Cancer Consortium, Seattle

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07094750

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT04282187

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Seattle Children's Hospital, Seattle
Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Mary Bridge Children's Hospital and Health Center, Tacoma
e mais 1

RecrutandoFase 3

6 Months – 21 Years · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT04293562

A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell Transplant

Fred Hutch/University of Washington Cancer Consortium, Seattle

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07616921

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Providence Sacred Heart Medical Center and Children's Hospital, Spokane

RecrutandoFase 3

Idades de 1 a 25 · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07022678

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1

Idades de 18 a 85 · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06834282

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Seattle Children's Hospital, Seattle
Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Mary Bridge Children's Hospital and Health Center, Tacoma
e mais 1

RecrutandoFase 1/2

Até 22 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Seattle Children's Hospital, Seattle

RecrutandoFase 3

29 Days – 21 Years · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

University of Washington, Seattle

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT06001788

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

Fred Hutch/University of Washington Cancer Consortium, Seattle

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT06710418

Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia

Fred Hutchinson Cancer Center/University of Washington Cancer Consortium, Seattle

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 13 de ago. de 2026 · NCT03737955

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06529731

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 2

6 Months – 65 Years · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT06013423

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 20 de jul. de 2026 · NCT07046078

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Fred Hutchinson Cancer Research Center, Seattle

RecrutandoEstudo observacional

Todas as idades · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT01351545

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 1/2

Idades de 18 a 75 · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT03128034

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 1/2

Idades de 18 a 75 · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT03670966

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 2Voluntários saudáveis bem-vindos

6 Months · Todos os sexos · Atualizado em 29 de mai. de 2026 · NCT04195633

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 1

Até 80 anos · Todos os sexos · Atualizado em 18 de mai. de 2026 · NCT03326921

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 1/2Voluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 15 de mai. de 2026 · NCT06928662

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Seattle Cancer Care Alliance, Seattle

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de abr. de 2026 · NCT04256317

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de abr. de 2026 · NCT04797767

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 13 de abr. de 2026 · NCT05732103

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 2

Idades de 18 a 66 · Todos os sexos · Atualizado em 17 de mar. de 2026 · NCT06859424

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 2

Idades de 1 a 60 · Todos os sexos · Atualizado em 12 de mar. de 2026 · NCT03970096

PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML

Seattle Children's Hospital, Seattle

RecrutandoFase 1

Até 30 anos · Todos os sexos · Atualizado em 23 de dez. de 2025 · NCT05105152

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

Fred Hutchinson Cancer Research Center, Seattle

RecrutandoFase 2

3 Months · Todos os sexos · Atualizado em 12 de nov. de 2025 · NCT02143830

Novel Digital Application for Patients With Acute Leukemia

Fred Hutchinson Cancer Research Center (FHCRC), Seattle

Recrutando

Idades de 18 a 120 · Todos os sexos · Atualizado em 10 de nov. de 2025 · NCT06472128

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2025 · NCT06501196

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Fred Hutchinson Cancer Center, Seattle

RecrutandoVoluntários saudáveis bem-vindos

Idades de 18 a 120 · Todos os sexos · Atualizado em 25 de jul. de 2025 · NCT05237258

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.